MYCOPHENOLATE MOFETIL INDUCED GINGIVAL ENLARGEMENT IN A PATIENT WITH LUPUS ENTERITIS AND NEPHRITIS: A RARE CASE REPORT

Mycophenolate mofetil (MMF), an immunosuppressant commonly used to prevent organ rejection and treat autoimmune diseases, has been associated with various side effects. Here, we present a rare case of MMF-induced gingival enlargement in a 36-year-old female patient diagnosed with lupus enteritis and nephritis. The patient, who was on MMF therapy, presented with complaints of swollen and bleeding gums. Clinical examination revealed significant gingival enlargement. The patient underwent nonsurgical treatment followed by gingivectomy and gingivoplasty. The MMF therapy was eventually discontinued by the patient's physician. At the one-year follow-up, the patient showed successful treatment outcomes with no recurrence of gingival enlargement. This case highlights the importance of monitoring oral health in patients on immunosuppressive therapy and the need for interdisciplinary collaboration between dental and medical professionals in managing such cases.